Cencora, Inc. (BMV:COR)

Market Cap	1.21T +24.7%
Revenue (ttm)	5.87T +7.4%
Net Income	29.26B +16.4%
EPS	149.98 +18.6%
Shares Out	n/a
PE Ratio	41.50
Forward PE	20.22
Dividend	43.29 (0.71%)
Ex-Dividend Date	Nov 14, 2025

Volume	120
Average Volume	320
Open	6,122.75
Previous Close	6,733.22
Day's Range	6,122.75 - 6,122.75
52-Week Range	5,310.36 - 6,733.22
Beta	n/a
RSI	63.84
Earnings Date	Feb 4, 2026

About Cencora

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company’s U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, ...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1871
• Employees: 51,000
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: COR

Financial Performance

In fiscal year 2025, Cencora's revenue was $321.33 billion, an increase of 9.31% compared to the previous year's $293.96 billion. Earnings were $1.55 billion, an increase of 2.99%.

Financial numbers in USD